Works matching DE "VINBLASTINE"

Results: 496

Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.

Published in:

Veterinary & Comparative Oncology, 2023, v. 21, n. 3, p. 503, doi. 10.1111/vco.12913

By:

Zimmerman, Kelley;
Walsh, Koranda A.;
Ferrari, Jonathan T.;
Keuler, Nicholas S.;
Atherton, Matthew J.;
Lenz, Jennifer A.

Publication type:

Article

Response rate to a single dose of vinblastine administered to dogs with treatment‐naive multicentric lymphoma.

Published in:

Veterinary & Comparative Oncology, 2018, v. 16, n. 4, p. 636, doi. 10.1111/vco.12433

By:

Harding, K.;
Bergman, N.;
Smith, A.;
Lindley, S.;
Szivek, A.;
Milner, R.;
Brawner, W.;
Lejeune, A.

Publication type:

Article

Reaction phenotyping of vinblastine metabolism in dogs.

Published in:

Veterinary & Comparative Oncology, 2016, v. 14, n. 2, p. 161, doi. 10.1111/vco.12084

By:

Achanta, S.;
Maxwell, L. K.

Publication type:

Article

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose-finding study.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 174, doi. 10.1111/j.1476-5829.2011.00261.x

By:

Robat, C.;
London, C.;
Bunting, L.;
McCartan, L.;
Stingle, N.;
Selting, K.;
Kurzman, I.;
Vail, D. M.

Publication type:

Article

Tyrosine kinase inhibitor special issue Tyrosine kinase inhibitor special issue.

Published in:

Veterinary & Comparative Oncology, 2012, v. 10, n. 3, p. 161, doi. 10.1111/j.1476-5829.2012.00339.x

By:

Thamm, Douglas H.

Publication type:

Article

Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.

Published in:

Veterinary & Comparative Oncology, 2009, v. 7, n. 3, p. 196, doi. 10.1111/j.1476-5829.2009.00190.x

By:

Cooper, Maureen;
Tsai, XinRu;
Bennett, Peter

Publication type:

Article

Dose-escalating vinblastine for the treatment of canine mast cell tumour.

Published in:

Veterinary & Comparative Oncology, 2008, v. 6, n. 2, p. 111, doi. 10.1111/j.1476-5829.2007.00147.x

By:

Vickery, K. R.;
Wilson, H.;
Vail, D. M.;
Thamm, D. H.

Publication type:

Article

Treatment of canine mast cell tumours with vinblastine, cyclophosphamide and prednisone: 35 cases (1997–2004).

Published in:

Veterinary & Comparative Oncology, 2007, v. 5, n. 3, p. 156, doi. 10.1111/j.1476-5829.2006.00125.x

By:

Camps-Palau, M. A.;
Leibman, N. F.;
Elmslie, R.;
Lana, S. E.;
Plaza, S.;
McKnight, J. A.;
Risbon, R.;
Bergman, P. J.

Publication type:

Article

Vinblastine and prednisolone chemotherapy for surgically excised grade III canine cutaneous mast cell tumours.

Published in:

Veterinary & Comparative Oncology, 2007, v. 5, n. 3, p. 168, doi. 10.1111/j.1476-5829.2007.00135.x

By:

Hayes, A.;
Adams, V.;
Smith, K.;
Maglennon, G.;
Murphy, S.

Publication type:

Article

Feline epitheliotrophic T-cell lymphoma with paraneoplastic eosinophilia – immunochemotherapy with vinblastine and human recombinant interferon α2b.

Published in:

2004

By:

Cave, T. A.;
Gault, E. A.;
Argyletd, D. J.

Publication type:

Book Chapter

Methyl jasmonic acid induced expression pattern of terpenoid indole alkaloid pathway genes in Catharanthus roseus seedlings.

Published in:

Plant Growth Regulation, 2010, v. 61, n. 3, p. 243, doi. 10.1007/s10725-010-9468-7

By:

Shu Wei

Publication type:

Article

Effect of plant growth regulators on the biosynthesis of vinblastine, vindoline and catharanthine in Catharanthus roseus.

Published in:

Plant Growth Regulation, 2010, v. 60, n. 2, p. 133, doi. 10.1007/s10725-009-9429-1

By:

Pan, Qifang;
Chen, Yu;
Wang, Quan;
Yuan, Fang;
Xing, Shihai;
Tian, Yuesheng;
Zhao, Jingya;
Sun, Xiaofen;
Tang, Kexuan

Publication type:

Article

Variations of vinblastine accumulation and redox state affected by exogenous H2O2 in Catharanthus roseus (L.) G. Don.

Published in:

Plant Growth Regulation, 2009, v. 57, n. 1, p. 15, doi. 10.1007/s10725-008-9320-5

By:

Zhonghua Tang;
Lei Yang;
Yuangang Zu;
Xiaorui Guo

Publication type:

Article

The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

Published in:

International Journal of Clinical Oncology, 2011, v. 16, n. 4, p. 345, doi. 10.1007/s10147-011-0188-4

By:

Gondo, Tatsuo;
Ohori, Makoto;
Hamada, Riu;
Tanaka, Ayako;
Satake, Naoya;
Takeuchi, Hisashi;
Nakashima, Jun;
Hatano, Tadashi;
Tachibana, Masaaki

Publication type:

Article

Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 4, p. 376, doi. 10.1007/s10147-010-0071-8

By:

Soga, Norihito;
Kise, Hideaki;
Arima, Kiminobu;
Sugimura, Yoshiki

Publication type:

Article

Wipe Sampling Method and Evaluation of Environmental Variables for Assessing Surface Contamination of 10 Antineoplastic Drugs by Liquid Chromatography/Tandem Mass Spectrometry.

Published in:

Annals of Work Exposures & Health, 2017, v. 61, n. 8, p. 1003, doi. 10.1093/annweh/wxx070

By:

Colombo, Manuel;
Jeronimo, Matthew;
Astrakianakis, George;
Apte, Chirag;
Chun-Yip Hon

Publication type:

Article

Fungal Elicitation Enhances Vincristine and Vinblastine Yield in the Embryogenic Tissues of Catharanthus roseus.

Published in:

Plants (2223-7747), 2023, v. 12, n. 19, p. 3373, doi. 10.3390/plants12193373

By:

Tonk, Dipti;
Mujib, Abdul;
Maqsood, Mehpara;
Khusrau, Mir;
Alsughayyir, Ali;
Dewir, Yaser Hassan

Publication type:

Article

Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate.

Published in:

Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 2, p. 83, doi. 10.1038/sj.pcan.4500299

By:

Amato, R J;
Bui, C;
Logothetis, C J

Publication type:

Article

Optimizing Survival of Patients With Marginally Operable Stage IIIA Non-Small-Cell Lung Cancer Receiving Chemoradiotherapy With or Without Surgery.

Published in:

2016

By:

Kai-Lin Yang;
Yih-Chen Chan;
Hui-Ling Ko;
Mau-Shin Chi;
Hsin-Ell Wang;
Pei-Sung Hsu;
Chen-Chun Lin;
Diana Yu-Wung Yeh;
Shang-Jyh Kao;
Jiunn-Song Jiang;
Kwan-Hwa Chi;
Yang, Kai-Lin;
Chang, Yih-Chen;
Ko, Hui-Ling;
Chi, Mau-Shin;
Wang, Hsin-Ell;
Hsu, Pei-Sung;
Lin, Chen-Chun;
Yeh, Diana Yu-Wung;
Kao, Shang-Jyh

Publication type:

journal article

A prospective study to examine the accuracies and efficacies of prediction systems for response to neoadjuvant chemotherapy for muscle invasive bladder cancer.

Published in:

Oncology Letters, 2018, v. 16, n. 5, p. 5775, doi. 10.3892/ol.2018.9330

By:

Kato, Yoichiro;
Zembutsu, Hitoshi;
Takata, Ryo;
Matsuura, Tomohiko;
Kato, Renpei;
Kanehira, Mitsugu;
Iwasaki, Kazuhiro;
Yamada, Noriyuki;
Katagiri, Toyomasa;
Sugai, Tamotsu;
Fujioka, Tomoaki;
Nakamura, Yusuke;
Obara, Wataru

Publication type:

Article

Immunostaining and time-lapse analysis of vinblastine-induced paracrystal formation in human A549 cells.

Published in:

Oncology Letters, 2014, v. 8, n. 6, p. 2387, doi. 10.3892/ol.2014.2549

By:

YUKA NAKAMURA;
YASUHITO ISHIGAKI

Publication type:

Article

Initial experience with carboplatin desensitization: A case series in a paediatric hospital.

Published in:

2018

By:

Rodríguez del Río, Pablo;
Escudero, Carmelo;
Sánchez‐García, Silvia;
Ibáñez, María Dolores;
Méndez Brea, Paula;
Andión, Maitane;
Ruano, David

Publication type:

Letter to the Editor

SKIN ULTRASTRUCTURE IN LETTERER-SIWE DISEASE TREATED WITH VINBLASTINE.

Published in:

British Journal of Dermatology, 1971, v. 84, n. 4, p. 335, doi. 10.1111/j.1365-2133.1971.tb14229.x

By:

Gianotti, F.;
Caputo, R.

Publication type:

Article

THERAPY OF HISTIOCYTOSIS X.

Published in:

British Journal of Dermatology, 1970, v. 82, n. 2, p. 169, doi. 10.1111/j.1365-2133.1970.tb15009.x

By:

Winkelmann, R. K.;
Burgert, E. Omer

Publication type:

Article

A COMPARATIVE STUDY OF THE EFFECTS OF ANTI-TUMOUR AND IMMUNOSUPPRESSIVE DRUGS ON ANTIBODY-FORMING AND ERYTHROPOIETIC CELLS.

Published in:

Clinical & Experimental Immunology, 1970, v. 6, n. 6, p. 861

By:

Floersheim, G. L.

Publication type:

Article

A case of Hodgkin's lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD.

Published in:

Journal of Blood Medicine, 2015, v. 6, p. 93, doi. 10.2147/JBM.S67664

By:

Chakraborty, Rajshekhar;
Reddy, Shiva Kumar;
Mukkamalla;
Gutzmore, Garfield;
Hon Cheung Chan

Publication type:

Article

Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 6, p. 795, doi. 10.1038/bmt.2015.57

By:

Strullu, M;
Thomas, C;
Le Deley, M-C;
Chevance, A;
Kanold, J;
Bertrand, Y;
Jubert, C;
Dalle, J-H;
Paillard, C;
Baruchel, A;
Lamant, L;
Michel, G;
Brugières, L

Publication type:

Article

Cost and effectiveness comparison of sirolimus versus standard treatment in Kasabach-Merritt phenomenon: a real-world evidence study in Thailand.

Published in:

Pediatric Hematology & Oncology, 2024, v. 41, n. 3, p. 229, doi. 10.1080/08880018.2023.2300485

By:

Tongruang, Chanikarn;
Wananukul, Siriwan;
Chatproedprai, Susheera;
Narkbunnam, Nattee;
Nitiyarom, Rattanavalai;
Sirachainan, Nongnuch;
Natesirinilkul, Rungrote;
Chaweephisal, Phumin;
Sosothikul, Darintr

Publication type:

Article

NAIL INVOLVEMENT IN LANGERHANS CELL HISTIOCYTOSIS.

Published in:

Pediatric Hematology & Oncology, 2007, v. 24, n. 1, p. 45, doi. 10.1080/08880010601001362

By:

Ashena, Zahra;
Alavi, Samin;
Arzanian, Mohammad Taghi;
Eshghi, Peyman

Publication type:

Article

SOX2, a stemness gene, induces progression of NSCLC A549 cells toward anchorage-independent growth and chemoresistance to vinblastine.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 6197, doi. 10.2147/OTT.S175810

By:

Choe, Chungyoul;
Kim, Hyewon;
Min, Sol;
Park, Sangkyu;
Seo, Jeongmin;
Roh, Sangho

Publication type:

Article

Induction of multiple drug resistance in HMEC-1 endothelial cells after long-term exposure to sunitinib.

Published in:

OncoTargets & Therapy, 2014, v. 7, p. 2249, doi. 10.2147/OTT.S67251

By:

Limin Huang;
Chaoquan Hu;
Di Benedetto, Mélanie;
Varin, Rémi;
Jielin Liu;
Li Wang;
Vannier, Jean-Pierre;
Jian Jin;
Janin, Anne;
He Lu;
Hong Li

Publication type:

Article

Localized epidermal necrolysis (erythema multiforme-like reaction) following intravenous injection of vinblastine.

Published in:

Journal of Cutaneous Pathology, 1991, v. 18, n. 5, p. 344, doi. 10.1111/j.1600-0560.1991.tb01547.x

By:

Arias, D.;
Requena, L.;
Hasson, A.;
Gutierrez, M.;
Domine, M.;
Martin, L.;
Barat, A.

Publication type:

Article

Evaluación del tratamiento con VAMP más radioterapia a campos involucrados, en pacientes pediáricos mexicanos con estadio temprano de linfoma de Hodgkin.

Published in:

Boletín Médico del Hospital Infantil de México, 2009, v. 66, n. 1, p. 60

By:

Olaya-Vargas, Alberto;
Velasco-Hidalgo, Liliana;
Rivera-Luna, Roberto;
Suastegui, Fabián;
Zarco, Amador

Publication type:

Article

BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.

Published in:

PLoS ONE, 2019, v. 14, n. 1, p. 1, doi. 10.1371/journal.pone.0210785

By:

Griffiths, Gareth O.;
Cowan, Richard A.;
Grigor, Kenneth M.;
Uscinska, Barbara M.;
Sydes, Matthew;
Russell, Martin

Publication type:

Article

Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.

Published in:

PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195401

By:

Luchsinger, Charlotte;
Aguilar, Marcelo;
Burgos, Patricia V.;
Ehrenfeld, Pamela;
Mardones, Gonzalo A.

Publication type:

Article

Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.

Published in:: Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e216, doi. 10.1016/j.clgc.2021.02.005
Publication type:: Article

DESMOID-TYPE FIBROMATOSIS IN CHILDREN. CLINICAL FEATURES, TREATMENT RESPONSE, AND LONG-TERM FOLLOW-UP.

Published in:

Medicina (Buenos Aires), 2020, v. 80, n. 5, p. 495

By:

FORTUNATI, DANIELA;
KAPLAN, JULIO;
MARTÍ, JESSICA LÓPEZ;
PONZONE, AGUSTINA;
INNOCENTI, SERGIO;
FISCINA, SILVINA;
CACCIAVILLANO, WALTER;
ZUBIZARRETA, PEDRO;
ROSE, ADRIANA

Publication type:

Article

Combination radical surgery and multiple sequential chemotherapy for the treatment of advanced carcinoma of the testis (stage III).

Published in:

1976

By:

Merrin, Claude;
Takita, Hiroshi;
Weber, Rolf;
Wajsman, Zew;
Baumgartner, George;
Murphy, Gerald P.;
Merrin, C;
Takita, H;
Weber, R;
Wajsman, Z;
Baumgartner, G;
Murphy, G P

Publication type:

journal article

Chemotherapy of endodermal sinus tumour (yolk sac tumour) of the ovary: preliminary communication.

Published in:

Journal of the Royal Society of Medicine, 1982, v. 75, n. 11, p. 888, doi. 10.1177/014107688207501113

By:

Wiltshaw, E.;
Gowing, N. F. C.;
Stuart-Harris, R.;
Barker, G. H.

Publication type:

Article

Griseofulvin stabilizes microtubule dynamics,activates p53 and inhibits the proliferation ofMCF-7 cells synergistically with vinblastine.

Published in:

BMC Cancer, 2010, v. 10, p. 213, doi. 10.1186/1471-2407-10-213

By:

Rathinasamy, Krishnan;
Jindal, Bhavya;
Asthana, Jayant;
Singh, Parminder;
Balaji, Petety V.;
Panda, Dulal

Publication type:

Article

An unusual fatal case of overdose of Vinblastine and review of literature.

Published in:

Australian Journal of Forensic Sciences, 2017, v. 49, n. 6, p. 704, doi. 10.1080/00450618.2016.1195874

By:

Ventura Spagnolo, Elvira;
Mondello, Cristina;
Indorato, Francesca;
Cardia, Luigi;
Raffino, Cataldo;
Cardia, Giulio;
Bartoloni, Giovanni

Publication type:

Article

Corrigendum.

Published in:: 2017
Publication type:: Correction Notice

A Review of Immune Checkpoint Inhibitors for the Management of Locally Advanced or Metastatic Urothelial Carcinoma.

Published in:

Pharmacotherapy, 2017, v. 37, n. 11, p. 1391, doi. 10.1002/phar.2033

By:

Hanna, Kirollos S.

Publication type:

Article

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, p. 351, doi. 10.1002/hon.3164_253

By:

Moskowitz, A.;
Savage, K.;
Feldman, T.;
Ganesan, N.;
Hancock, H.;
Davey, T.;
Perez, L.;
Santarosa, A.;
Subzwari, S.;
Capadona, C.;
Yang, C.;
Galasso, N.;
David, K.;
Epstein‐Peterson, Z.;
Khan, N.;
Kumar, A.;
Hamlin, P.;
Ghione, P.;
Lue, J.;
Straus, D.

Publication type:

Article

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA.

Published in:

Hematological Oncology, 2023, v. 41, p. 161, doi. 10.1002/hon.3163_107

By:

Torka, P.;
Feldman, T.;
Savage, K.;
Ganesan, N.;
Hancock, H.;
Davey, T.;
Perez, L.;
Santarosa, A.;
Subzwari, S.;
Capadona, C.;
Yang, C.;
Galasso, N.;
David, K.;
Epstein‐Peterson, Z.;
Khan, N.;
Kumar, A.;
Hamlin, P.;
Ghione, P.;
Lue, J.;
Straus, D.

Publication type:

Article

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

Published in:

Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838

By:

Hutchings, Martin;
Radford, John;
Ansell, Stephen M.;
Illés, Árpád;
Sureda, Anna;
Connors, Joseph M.;
Sýkorová, Alice;
Shibayama, Hirohiko;
Abramson, Jeremy S.;
Chua, Neil S.;
Friedberg, Jonathan W.;
Kořen, Jan;
LaCasce, Ann Steward;
Molina, Lysiane;
Engley, Gerald;
Fenton, Keenan;
Jolin, Hina;
Liu, Rachael;
Gautam, Ashish;
Gallamini, Andrea

Publication type:

Article

Comparison of Furosemide and Vinblastine Secretion from Cell Lines Overexpressing Multidrug Resistance Protein (P-Glycoprotein) and Multidrug Resistance-Associated Proteins (MRP1 and MRP2).

Published in:

Pharmacology, 2002, v. 64, n. 3, p. 126, doi. 10.1159/000056161

By:

Flanagan, Shawn D.;
Cummins, Carolyn L.;
Susanto, Miki;
Xiaoli Liu;
Takahashi, Lori H.;
Benet, Leslie Z.

Publication type:

Article

Effects of Organic Anions and Vinblastine on Biliary Excretion of Erythromycin in Rats.

Published in:

Pharmacology, 1999, v. 59, n. 5, p. 249, doi. 10.1159/000028327

By:

Sato, Akihiro;
Takikawa, Hajime;
Yamanaka, Masami

Publication type:

Article

Langerhans cell histiocytosis: vanishing mandible in a 10-year-old.

Published in:

Acta Oto-Laryngologica Case Reports, 2016, v. 1, n. 1, p. 36, doi. 10.1080/23772484.2016.1209639

By:

Dy, Alexander Edward S.;
Cabungcal, Arsenio Claro A.;
Pangan, Roberto M.

Publication type:

Article

Discovery of active site of vinblastine as application of nanotechnology in medicine.

Published in:

Nanomedicine Journal, 2014, v. 1, n. 3, p. 162

By:

Varmaghani, Zahra;
Monajjemi, Majid;
Mollaamin, Fatemeh

Publication type:

Article